Second death linked to J&J jab - Sahpra
Health product regulators say a second death's been linked to the Johnson & Johnson Covid-19 vaccine.
This person was also diagnosed with Guillian Barre syndrome, a very rare but potentially severe condition that affects the nerves.
Sahpra released a statement last night to say that the case was classified as a "vaccine product-related event".
This was after the National Immunisation Safety Expert Committee conducted investigations and causality assessments - using the WHO's methodology.
READ: First confirmed death from Covid jab in South Africa
The authority's Yuven Gounden says the first death related to GBS and the vaccine was reported last month.
"Regulatory authorities have previously investigated GBS associated with Covif-19 vaccines. They concluded that Covid-19 vaccine Janssen may increase the risk of GBS.
"GBS is therefore listed as a rare adverse event in the professional information for the Covid-19 vaccine Janssen. Sahpra urges the public to report any adverse events following the use of all medicines and vaccines."
Sahpra stressed that the benefits of the Covid jabs far outweigh the very low risk of severe adverse events, including Gill-lan Barray Syndrome.
Sahpra's says the Covid-19 vaccines have consistently shown to prevent severe forms of the disease, hospitalisation and death.
MORE ON ECR
